Highly promising antitumor agent of a novel Platinum(II) complex bearing a tetradentate chelating ligand
dc.authorid | Engin Ulukaya / 0000-0003-4875-5472 | en_US |
dc.authorid | Remzi Okan Akar / 0000-0001-8687-2034 | |
dc.authorid | Merve Erkısa Genel / 0000-0002-3127-742X | |
dc.authorscopusid | Engin Ulukaya / 6602927353 | |
dc.authorscopusid | Remzi Okan Akar / 57210603359 | |
dc.authorscopusid | Selin Selvi / 57210599688 | |
dc.authorscopusid | Merve Erkısa Genel / 57126208900 | |
dc.authorwosid | Engin Ulukaya / K-5792-2018 | |
dc.authorwosid | Remzi Okan Akar / AAF-4576-2019 | |
dc.authorwosid | Selin Selvi / FZU-0996-2022 | |
dc.authorwosid | Merve Erkısa Genel / AAM-1001-2020 | |
dc.contributor.author | Yılmaz, İsmail | |
dc.contributor.author | Akar, Remzi Okan | |
dc.contributor.author | Erkısa Genel, Merve | |
dc.contributor.author | Selvi, Selin | |
dc.contributor.author | Şengül, Abdurrahman | |
dc.contributor.author | Ulukaya, Engin | |
dc.date.accessioned | 2020-08-30T20:06:11Z | |
dc.date.available | 2020-08-30T20:06:11Z | |
dc.date.issued | 2020 | |
dc.department | İstinye Üniversitesi, Rektörlük | en_US |
dc.description | YILMAZ, ismail/0000-0002-0139-0122; Erkisa, Merve/0000-0002-3127-742X; Ulukaya, Engin/0000-0003-4875-5472; AKAR, Okan/0000-0001-8687-2034 | en_US |
dc.description | Akar, Okan Remzi ; Erkisa Genel, Merve ; Selvi, Selin ; Ulukaya, Engin (isu author) | en_US |
dc.description.abstract | A new mononuclear cationic platinum(II) coordination compound with 6,6'-bis(NH-benzimidazol-2-yl)-2,2'-bipyridine (L) ligand having N-4-tetradentate binding pocket [Pt(L)]-Cl-2.2H(2)O (Complex 1) was synthesized and characterized by FTIR(ATR), UV-vis, H-1 NMR, APCI and MALDI MS, and CHN analysis. The antigrowth effect of Complex 1 was tested in breast cancer (MDA-MB-231), lung cancer (A549), colorectal cancer (HCT-116), prostate cancer (PC-3) cell lines, and bronchial epithelial cell line (BEAS-2B) by the SRB and ATP cell viability assays. Apoptosis was detected with Annexin V, mitopotential, BCL-2 inactivation, and gamma H2AX assays by flow cytometry. Complex 1 was found to have cytotoxic activity of MDA-MB-231, A549, HCT-116, and PC-3 cancer cell lines in a dose-dependent manner for 48 h. Complex 1 has been found to cause cell death through different mechanisms depending on the type of cancer. The findings indicated that complex induced intrinsic apoptosis with the increased mitochondrial membrane depolarization level, Bcl-2 inactivation, and DNA damage in PC-3 and A549 cell lines. | en_US |
dc.description.sponsorship | Turkish Scientific and Technical Research Council (TUBITAK)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [TBAG-2450(104T060)] | en_US |
dc.description.sponsorship | This work was partly supported by the Turkish Scientific and Technical Research Council (TUBITAK) [grant number TBAG-2450(104T060)]. | en_US |
dc.identifier.citation | Yilmaz, I., Akar, O. R., Erkisa, M., Selvi, S., Sengul, A., & Ulukaya, E. (2020). Highly Promising Antitumor Agent of a Novel Platinum(II) Complex Bearing a Tetradentate Chelating Ligand. ACS MEDICINAL CHEMISTRY LETTERS, 11(5), 940–948. https://doi.org/10.1021/acsmedchemlett.9b00676 | en_US |
dc.identifier.doi | 10.1021/acsmedchemlett.9b00676 | en_US |
dc.identifier.endpage | 948 | en_US |
dc.identifier.issn | 1948-5875 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.pmid | 32435409 | en_US |
dc.identifier.scopus | 2-s2.0-85082528330 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 940 | en_US |
dc.identifier.uri | https://doi.org/10.1021/acsmedchemlett.9b00676 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/409 | |
dc.identifier.volume | 11 | en_US |
dc.identifier.wos | WOS:000535281200051 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Akar, Remzi Okan | en_US |
dc.institutionauthor | Erkısa Genel, Merve | en_US |
dc.institutionauthor | Selvi, Selin | en_US |
dc.institutionauthor | Ulukaya, Engin | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Chemical Soc | en_US |
dc.relation.ispartof | Acs Medicinal Chemistry Letters | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Platinum | en_US |
dc.subject | N-4-Donor Ligand | en_US |
dc.subject | Benzimidazole | en_US |
dc.subject | Pyridine | en_US |
dc.subject | Cytotoxicity | en_US |
dc.subject | Apoptosis | en_US |
dc.title | Highly promising antitumor agent of a novel Platinum(II) complex bearing a tetradentate chelating ligand | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- 159.pdf
- Boyut:
- 5.28 MB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text